CANNABINOID CLINICAL
SCIENCE, TECHNOLOGY & HEALTH
For more than 10 years the team at CannaCure™ has worked tirelessly researching the medical benefits of CBD, THC and other cannabinoids. These efforts have resulted in travel to Asia, Europe, Latin America and more than 20 U.S. states and Washington D.C. with biotech companies, experts in genetics, organic cultivators, farmers, extraction companies, technology companies, processors, packagers, health care providers, healthcare industry leaders, healthcare insurance companies, some of the world's largest retailers, federal, state and local government agencies, and others.
AMA APPLAUDS U.S. SURGEON GENERAL
HARVESTING, PROCESSING & EXTRACTION
CannaCure™ has teamed up with experienced professionals in several key industries, such as; genetics, farming, leading edge cultivation technologies, processing, energy, LED and Co2 supercritical extraction of both cannabis and hemp plants. . These team members and alliances, along with the vertical integration structured by CannaCure™ are key aspects for CannaCure™ to execute streamlined operations with both the highest efficiencies and the highest efficacy from seed to sale. This allows CannaCure™ to provide the highest quality products to consumers worldwide.
Dr. Raphael Mechoulam, the Godfather of Cannabis Research, is the researcher and professor who is responsible for first isolating THC & CBD delivered an engaging, informative keynote address at the 2019 International Cannabis Business Conference in Berlin.
Dr. Ruth Ross describes what happens in the brain when introduced to tetrahydrocannabinol (THC), one of the primary ingredients in cannabis. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
At 2004 Cannabis Therapeutics Conference at the University of Virginia School of Medicine, Dr. Mechoulam, Professor at Hebrew University in Jerusalem describes the role of Cannabinoids as anti-inflammatory for arthritis, as a neuroprotectant for brain injury and as a possible treatment for PTSD
BRITISH PHARMACOLOGICAL SOCIETY
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2125.2012.04298.x
CANNABINOIDS & THC
The amazing discoveries of Dr. Raphael Mechoulam who in 1964 discovered the first cannabinoid "CBD" and in 1992 discovered the endocannabinoid system in the human body. These groundbreaking discoveries have led to many clinically proven medical treatments using CBD (non-psychoactive), THC (psychoactive) and various combinations of more than 100 psychoactive and no-psychoactive cannabinoids. In 2018, the U.S. farm bill passed to allow for the harvesting of hemp in all 50 states and there are now more than 30 U.S. states have approved medical marijuana. Some states passed laws for the recreational use and several countries, like Canada have approved recreational use.